IMARC Group has recently released a new research study titled “South Korea Healthcare Cold Chain Logistics Market Report by Product (Biopharmaceuticals, Vaccines, Clinical Trials), Segment (Transportation, Packaging, Instrumentation), and Region 2025-2033.”, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends and competitive landscape to understand the current and future market scenarios.
South Korea Healthcare Cold Chain Logistics Market Overview
The South Korea healthcare cold chain logistics market size was valued at USD 302.4 Million in 2024. It is projected to reach USD 852.2 Million by 2033, growing at a compound annual growth rate (CAGR) of 11.2% during the forecast period of 2025 to 2033. This market supports the safe transportation and storage of temperature-sensitive healthcare products such as vaccines using advanced digital systems for real-time monitoring, boosting demand for sophisticated cold chain logistics solutions across South Korea.
Study Assumption Years
- Base Year: 2024
- Historical Years: 2019-2024
- Forecast Period: 2025-2033
South Korea Healthcare Cold Chain Logistics Market Key Takeaways
- Current Market Size: USD 302.4 Million (2024)
- CAGR: 11.2% (2025-2033)
- Forecast Period: 2025-2033
- The rising prevalence of infectious and chronic disorders is driving demand for vaccines and biopharmaceuticals in South Korea.
- Integration of augmented reality (AR), blockchain, and the Internet of Things (IoT) enables predictive alerts for warehouse management and delivery.
- Increased need for transporting sophisticated clinical trial specimens and biologics is a significant growth driver.
- Transportation segment currently holds the majority of the market share.
- The vaccine product category exhibits clear market dominance.
Sample Request Link: https://www.imarcgroup.com/south-korea-healthcare-cold-chain-logistics-market/requestsample
